Apellis Pharmaceuticals Inc
APLS
Market Cap$2.13B
Close$
$-40.45
309.8% downside
Current Fair Value
309.8% downsideOvervalued by 309.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.13 Billion |
|---|---|
| Enterprise Value | $2.24 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.6 |
| Beta | 0.72 |
| Outstanding Shares | 125,453,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.5 |
|---|---|
| PEG | -24.44 |
| Price to Sales | 3.86 |
| Price to Book Ratio | 19.28 |
| Enterprise Value to Revenue | 3.05 |
| Enterprise Value to EBIT | -10.02 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 2.86 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Apellis Pharmaceuticals Inc
CEO: Cedric Francois